releases: http://sires.house.gov/media-center/press-releases/sires-resolution-on-providing-oversight-on-usaid-unanimously-passes
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| http://sires.house.gov/media-center/press-releases/sires-resolution-on-providing-oversight-on-usaid-unanimously-passes | Sires Resolution on Providing Oversight on USAID Unanimously Passes House of Representatives | 2015-12-18 | 2015 | 2015-12 | Democrat | House | NJ | Albio Sires | S001165 | sires.house.gov | legacy | (Washington, D.C.) -Today, H.R. 2241, the Global Health Innovation Act, introduced by Congressman Albio Sires, passed the House of Representatives by voice vote. Infectious diseases and other health conditions still claim the lives of nearly 9 million people each year. To improve the United States'leadership in global health care, Rep. Albio Sires and Rep. Mario Diaz-Balart (R-FL) introduced legislation to promote the development of health products that are affordable, culturally appropriate, and easy to use in low-resource health systems. "U.S. investments in global health research are central components of our foreign policy and help increase national security, strengthen U.S. relations around the world, and reduce infectious diseases. The U.S. has a legacy of leadership in global health research over the years and USAID's work has helped for advancements towards an HIV and AIDS free generation, preventable maternal and childhood deaths, and preventable infectious diseases,"stated Congressman Sires. "I am proud to sponsor this legislation with Rep. Mario Diaz-Balart, and grateful for the support of my colleagues in passing this bill. I look forward to H.R. 2241 now being brought before the Senate for consideration." Specifically, H.R. 2241 will provide the oversight needed to gain a clearer picture of the United States Agency for International Development's (USAID) global health research and development. Over the years, research and development projects have greatly expanded at USAID, searching for advancements towards an HIV and AIDS free generation, preventable maternal and childhood deaths, and preventable infectious diseases. H.R. 2241 directs the USAID Administrator to report to Congress on the development and use of global health innovations in USAID programs, projects, and activities, ensuring that taxpayer dollars are being spent in the most efficient and effective ways possible. Rep. Mario Diaz-Balart (R-FL) stated, "As the number of fatal infectious disease and other health conditions continue to be a global concern, USAID's role is critical. The research and development of health products will help combat these diseases, especially in areas lacking access to health care. I want to thank Congressman Sires for his leadership in the fight against these fatal diseases. I look forward to continue working with him and our congressional colleagues on this issue." H.R. 2241 currently awaits action in the Senate. Text of H.R. 2241 can be seen here. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |